日祥參加第13屆亞洲口腔顎面外科學大會
第13屆亞洲口腔顎面外科學大會 (Asian Congress on Oral and Maxillofacial Surgery, ACOMS)係由亞洲口腔顎面外科協會主辦，於2018年11月8日至11月11日假台北萬豪酒店舉辦，與會人士包含來自22個國家，約900名醫師學者參與。日祥透過本次展覽開拓更多合作機會，充分與國際間各層級醫療院所醫師或學者近距離交流，有效推廣Oral-M®進而提升日祥與EpiGene品牌形象。
更多資訊請瀏覽: https://tw.epigenebio.com/
 |
 |
|||||||
 |
|
圖片來源：日祥公司
|
|
iStat Biomedical promotes Oral-M® at ACOMS 2018 |
The 13th Asian Congress of Oral and Maxillofacial Surgery (ACOMS) is held at Taipei Marriott Hotel from 8th to 11th, November 2018. Participators included 900 physicians and scientists from 22 countries. iStat Biomedical Co., Ltd. is honored to be part of this event with great opportunities in promoting Oral-M® and branding EpiGene, moreover to exchange experiences in fighting oral cancer.
For more information, please visit: https://tw.epigenebio.com/
About iStat Biomedical
iStat Biomedical is a Taiwan-based biotechnology company specialized in the development and manufacturing of gene methylation assay IVD products for the early detection of cancers. iStat Biomedical develops innovative products that are primarily used in the clinical laboratories, and provides physicians with alternative solutions for clinical managements. iStat Biomedical also provides services for gene methylation detection and IVD contract manufacturing.
iStat Biomedical Co., Ltd contact:
+886-2-26963518
第13屆亞洲口腔顎面外科學大會 (Asian Congress on Oral and Maxillofacial Surgery, ACOMS)係由亞洲口腔顎面外科協會主辦，於2018年11月8日至11月11日假台北萬豪酒店舉辦，與會人士包含來自22個國家，約900名醫師學者參與。日祥透過本次展覽開拓更多合作機會，充分與國際間各層級醫療院所醫師或學者近距離交流，有效推廣Oral-M®進而提升日祥與EpiGene品牌形象。
更多資訊請瀏覽: https://tw.epigenebio.com/
|
|
|||||||
|
|
圖片來源：日祥公司
|
|
iStat Biomedical promotes Oral-M® at ACOMS 2018 |
The 13th Asian Congress of Oral and Maxillofacial Surgery (ACOMS) is held at Taipei Marriott Hotel from 8th to 11th, November 2018. Participators included 900 physicians and scientists from 22 countries. iStat Biomedical Co., Ltd. is honored to be part of this event with great opportunities in promoting Oral-M® and branding EpiGene, moreover to exchange experiences in fighting oral cancer.
For more information, please visit: https://tw.epigenebio.com/
About iStat Biomedical
iStat Biomedical is a Taiwan-based biotechnology company specialized in the development and manufacturing of gene methylation assay IVD products for the early detection of cancers. iStat Biomedical develops innovative products that are primarily used in the clinical laboratories, and provides physicians with alternative solutions for clinical managements. iStat Biomedical also provides services for gene methylation detection and IVD contract manufacturing.
iStat Biomedical Co., Ltd contact:
+886-2-26963518